Prelude Therapeutics Inc

SEC 4 · Filed

0001825005-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 4, 2026

Grant, award or other acquisition by Combs Andrew

Security
Employee Stock Option (right to buy)
Code
A
Shares
230,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-04",
  "direction": "A",
  "exercise_price": "2.30",
  "expiration": "2036-02-03",
  "footnotes": {
    "F1": "The stock option vests as to 25% of the total shares on Feb 4, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person\u0027s provision of service to the Issuer on each vesting date."
  },
  "owners": [
    {
      "cik": "0001825005",
      "name": "Combs Andrew",
      "roles": [
        "officer"
      ],
      "title": "Chief Chemistry Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "230000.00",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Employee Stock Option (right to buy)",
  "shares": "230000.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "230000.00"
}